Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles.

Haughney SL, Petersen LK, Schoofs AD, Ramer-Tait AE, King JD, Briles DE, Wannemuehler MJ, Narasimhan B.

Acta Biomater. 2013 Sep;9(9):8262-71. doi: 10.1016/j.actbio.2013.06.006. Epub 2013 Jun 14.

2.

Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens.

Carrillo-Conde B, Schiltz E, Yu J, Chris Minion F, Phillips GJ, Wannemuehler MJ, Narasimhan B.

Acta Biomater. 2010 Aug;6(8):3110-9. doi: 10.1016/j.actbio.2010.01.040. Epub 2010 Feb 1.

PMID:
20123135
3.

Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.

Yamamoto M, McDaniel LS, Kawabata K, Briles DE, Jackson RJ, McGhee JR, Kiyono H.

Infect Immun. 1997 Feb;65(2):640-4.

4.

Structural and antigenic stability of H5N1 hemagglutinin trimer upon release from polyanhydride nanoparticles.

Ross KA, Loyd H, Wu W, Huntimer L, Wannemuehler MJ, Carpenter S, Narasimhan B.

J Biomed Mater Res A. 2014 Nov;102(11):4161-8. doi: 10.1002/jbm.a.35086. Epub 2014 Feb 4.

PMID:
24443139
5.

Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae.

Kong IG, Sato A, Yuki Y, Nochi T, Takahashi H, Sawada S, Mejima M, Kurokawa S, Okada K, Sato S, Briles DE, Kunisawa J, Inoue Y, Yamamoto M, Akiyoshi K, Kiyono H.

Infect Immun. 2013 May;81(5):1625-34. doi: 10.1128/IAI.00240-13. Epub 2013 Mar 4.

6.
7.

Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA.

Briles DE, Hollingshead SK, King J, Swift A, Braun PA, Park MK, Ferguson LM, Nahm MH, Nabors GS.

J Infect Dis. 2000 Dec;182(6):1694-701. Epub 2000 Nov 8.

8.

High throughput cell-based screening of biodegradable polyanhydride libraries.

Adler AF, Petersen LK, Wilson JH, Torres MP, Thorstenson JB, Gardner SW, Mallapragada SK, Wannemuehler MJ, Narasimhan B.

Comb Chem High Throughput Screen. 2009 Aug;12(7):634-45. Epub 2009 Aug 1.

PMID:
19531023
9.

PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice.

Briles DE, King JD, Gray MA, McDaniel LS, Swiatlo E, Benton KA.

Vaccine. 1996 Jun;14(9):858-67.

PMID:
8843627
10.

Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres.

Lopac SK, Torres MP, Wilson-Welder JH, Wannemuehler MJ, Narasimhan B.

J Biomed Mater Res B Appl Biomater. 2009 Nov;91(2):938-47. doi: 10.1002/jbm.b.31478.

11.

Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.

Bitsaktsis C, Iglesias BV, Li Y, Colino J, Snapper CM, Hollingshead SK, Pham G, Gosselin DR, Gosselin EJ.

Infect Immun. 2012 Mar;80(3):1166-80. doi: 10.1128/IAI.05511-11. Epub 2011 Dec 12.

12.

Evaluation of a vaccine formulation against Streptococcus pneumoniae based on choline-binding proteins.

Miyaji EN, Vadesilho CF, Oliveira ML, Zelanis A, Briles DE, Ho PL.

Clin Vaccine Immunol. 2015 Feb;22(2):213-20. doi: 10.1128/CVI.00692-14. Epub 2014 Dec 17.

13.

Polymer chemistry influences monocytic uptake of polyanhydride nanospheres.

Ulery BD, Phanse Y, Sinha A, Wannemuehler MJ, Narasimhan B, Bellaire BH.

Pharm Res. 2009 Mar;26(3):683-90. doi: 10.1007/s11095-008-9760-7. Epub 2008 Nov 6.

PMID:
18987960
14.

Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.

Nguyen CT, Kim SY, Kim MS, Lee SE, Rhee JH.

Vaccine. 2011 Aug 5;29(34):5731-9. doi: 10.1016/j.vaccine.2011.05.095. Epub 2011 Jun 13.

PMID:
21696869
15.

Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.

Langermann S, Palaszynski SR, Burlein JE, Koenig S, Hanson MS, Briles DE, Stover CK.

J Exp Med. 1994 Dec 1;180(6):2277-86.

16.

A nontoxic adjuvant for mucosal immunity to pneumococcal surface protein A.

Yamamoto M, Briles DE, Yamamoto S, Ohmura M, Kiyono H, McGhee JR.

J Immunol. 1998 Oct 15;161(8):4115-21.

17.

Harvesting murine alveolar macrophages and evaluating cellular activation induced by polyanhydride nanoparticles.

Chavez-Santoscoy AV, Huntimer LM, Ramer-Tait AE, Wannemuehler M, Narasimhan B.

J Vis Exp. 2012 Jun 8;(64):e3883. doi: 10.3791/3883.

18.

A bivalent vaccine based on a replication-incompetent influenza virus protects against Streptococcus pneumoniae and influenza virus infection.

Katsura H, Piao Z, Iwatsuki-Horimoto K, Akeda Y, Watanabe S, Horimoto T, Oishi K, Kawaoka Y.

J Virol. 2014 Nov;88(22):13410-7. doi: 10.1128/JVI.01205-14. Epub 2014 Sep 10.

19.

Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae.

Briles DE, Yother J, McDaniel LS.

Rev Infect Dis. 1988 Jul-Aug;10 Suppl 2:S372-4.

PMID:
3187321
20.

PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae.

Miyaji EN, Dias WO, Gamberini M, Gebara VC, Schenkman RP, Wild J, Riedl P, Reimann J, Schirmbeck R, Leite LC.

Vaccine. 2001 Dec 12;20(5-6):805-12.

PMID:
11738744
Items per page

Supplemental Content

Write to the Help Desk